The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis

Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: A systematic review and meta-analysis

(2013) Qianqian Zhu et al.   ANTIVIRAL RESEARCH

Decreased IP-10 and Elevated TGFβ1 Levels are Associated with Viral Clearance Following Therapy in Patients with Hepatitis C Virus

(2013) Silvia Lee et al.   DISEASE MARKERS

A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients

(2013) T. Bader et al.   JOURNAL OF VIRAL HEPATITIS

SKI-1/S1P inhibition: A promising surrogate to statins to block Hepatitis C virus replication

(2012) Matthieu Blanchet et al.   ANTIVIRAL RESEARCH

Resveratrol prevents hepatic steatosis induced by hepatitis C virus core protein

(2012) Lina Jiang et al.   BIOTECHNOLOGY LETTERS

1092 EFFECTS OF PRE-TREATMENT WITH BEZAFIBRATE FOLLOWED BY STANDARD OF CARE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION AND ELEVATED GGT LEVELS

(2012) A. Bohlig et al.   JOURNAL OF HEPATOLOGY

PPARs and HCV-Related Hepatocarcinoma: A Mitochondrial Point of View

(2012) Francesca Agriesti et al.   PPAR Research

Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)

(2012) David A. Sheridan et al.   Clinics and Research in Hepatology and Gastroenterology

Effects of Simvastatin in Patients with Viral Chronic Hepatitis C

(2011) Romeo-Gabriel Mihaila et al.   HEPATO-GASTROENTEROLOGY

Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy

(2011) Christian M. Lange et al.   HEPATOLOGY

The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection

(2011) Viola Weich et al.   JOURNAL OF GASTROENTEROLOGY

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirin

(2010) Christian M. Lange et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C

(2010) Gowtham A. Rao et al.   GASTROENTEROLOGY

Early Menopause Is Associated With Lack of Response to Antiviral Therapy in Women With Chronic Hepatitis C

(2010) Erica Villa et al.   GASTROENTEROLOGY

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

(2010) Stephen A. Harrison et al.   HEPATOLOGY

Associations between serum lipids and hepatitis C antiviral treatment efficacy

(2010) Darmendra Ramcharran et al.   HEPATOLOGY

Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study

(2010) L. Milazzo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C

(2010) K. Patel et al.   JOURNAL OF VIRAL HEPATITIS

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

(2010) Paul Y Kwo et al.   LANCET

Statins for the Prevention and Treatment of Infections

(2009) Imad M. Tleyjeh   ARCHIVES OF INTERNAL MEDICINE

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients

(2009) Thomas Berg et al.   HEPATOLOGY

Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development

(2009) Leen Delang et al.   HEPATOLOGY

Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up

(2009) Kathleen E. Corey et al.   HEPATOLOGY

An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads

(2009) Hitomi Sezaki et al.   INTERVIROLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

(2009) Christophe Hézode et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis C virus hijacks host lipid metabolism

(2009) Gulam H. Syed et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism

(2009) Rodney K. Lyn et al.   VIROLOGY

Do statins reduce hepatitis C RNA titers during routine clinical use?

(2009) Kimberly A Forde et al.   WORLD JOURNAL OF GASTROENTEROLOGY

HCV Replication and Statin Pleotropism: An Adjuvant Treatment Panacea?

(2008) Dawn M. Torres et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fluvastatin Inhibits Hepatitis C Replication in Humans

(2008) Ted Bader et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY